Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Vertex Pharmaceuticals
VRTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$474.16
-7.1
-1.48%
At Close: -
$474.16
0
0.00%
After Hours: 4:27 PM EDT
15 minutes delayed
Get Report
Comment
Vertex Pharmaceuticals (VRTX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock
Vertex Pharmaceuticals Stock (NASDAQ: VRTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, September 18, 2024
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Benzinga Insights
Friday, September 06, 2024
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
Benzinga Insights
Thursday, August 29, 2024
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
Benzinga Insights
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Avi Kapoor
Tuesday, August 27, 2024
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Benzinga Insights
Friday, August 23, 2024
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Benzinga Insights
Wednesday, August 21, 2024
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
Benzinga Insights
Tuesday, August 20, 2024
NSA Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
Kaustubh Bagalkote
Thursday, August 15, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, August 09, 2024
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Benzinga Insights
Thursday, August 08, 2024
Editas Q2 Earnings & Revenues Miss Estimates, Stock Down
Zacks
Reported Earlier, Vertex Secures NHS England ...
Benzinga Newsdesk
Monday, August 05, 2024
HC Wainwright & Co. Maintains Buy on Vertex P...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Vertex Ph...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Vertex Phar...
Benzinga Newsdesk
Truist Securities Reiterates Buy on Vertex Ph...
Benzinga Newsdesk
Vertex Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Barclays Downgrades Vertex Pharmaceuticals to...
Benzinga Newsdesk
Friday, August 02, 2024
Guggenheim Maintains Buy on Vertex Pharmaceut...
Benzinga Newsdesk
Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?
Piero Cingari
Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline
Vandana Singh
Cantor Fitzgerald Reiterates Overweight on Ve...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Vertex ...
Benzinga Newsdesk
Thursday, August 01, 2024
Vertex Pharmaceuticals Raises FY24 Revenue Gu...
Benzinga Newsdesk
Vertex Pharmaceuticals Q2 Adj $(12.83) Misses...
Benzinga Newsdesk
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
Piero Cingari
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
Shanthi Rexaline
Wednesday, July 31, 2024
Should You Invest in the iShares Biotechnology ETF?
Zacks
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
Benzinga Insights
Canaccord Genuity Maintains Sell on Vertex Ph...
Benzinga Newsdesk
Tuesday, July 30, 2024
Vertex Announces FDA AcceptanceOf New Drug Ap...
Benzinga Newsdesk
Monday, July 29, 2024
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
Shanthi Rexaline
Friday, July 26, 2024
Needham Reiterates Hold on Vertex Pharmaceuti...
Benzinga Newsdesk
Tuesday, July 23, 2024
TD Cowen Maintains Buy on Vertex Pharmaceutic...
Benzinga Newsdesk
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
Benzinga Insights
Monday, July 22, 2024
Cantor Fitzgerald Maintains Overweight on Ver...
Benzinga Newsdesk
Friday, July 19, 2024
HC Wainwright & Co. Maintains Buy on Vertex P...
Benzinga Newsdesk
Tuesday, July 16, 2024
Genomics Extends And Expansion Drug Discovery...
Benzinga Newsdesk
Monday, July 15, 2024
Vertex Seeks Court Confirmation That Financia...
Benzinga Newsdesk
Vertex Pharmaceuticals Sues U.S. Department O...
Benzinga Newsdesk
Health Canada Grants Marketing Authorization ...
Benzinga Newsdesk
Thursday, July 11, 2024
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Vert...
Benzinga Newsdesk
Wednesday, July 10, 2024
Check Out What Whales Are Doing With VRTX
Benzinga Insights
Tuesday, July 02, 2024
Vertex Pharmaceuticals Announces FDA Acceptan...
Benzinga Newsdesk
Monday, July 01, 2024
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today
Benzinga Insights
Thursday, June 27, 2024
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Redburn Atlantic Initiates Coverage On Vertex...
Benzinga Newsdesk
Wednesday, June 26, 2024
Peering Into Vertex Pharmaceuticals's Recent Short Interest
Benzinga Insights
Monday, June 24, 2024
Wells Fargo Maintains Overweight on Vertex Ph...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch